Home / Import refusals / AEK-9026661-8/10003/1

FDA Import Refusal AEK-9026661-8/10003/1 — Cipla Limited

Cipla Limited — FEI 3002806691

The FDA refused shipment AEK-9026661-8/10003/1 from Cipla Limited (India) on December 12, 2025. The refused product falls under Drugs and Biologics — CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC). Cited charge: 118 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 12, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61FDY54 CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
Charges
118

Recent inspections

  • 1254500 (VAI Wed Nov 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1160347 (VAI Fri Jan 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099619 (VAI Fri Jul 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009388 (VAI Wed Apr 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 891868 (VAI Fri Jul 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-3441591-9/20002/4 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-1905741-3/20002/4 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-1905741-3/20002/5 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4688178-4/10002/1 (Tue Jun 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-9797841-4/20002/1 (Tue Jun 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources